Skip to main content
Have a personal or library account? Click to login
The Prothrombin Factor II G20210A Mutation with Pulmonary Thromboembolism and a Normal Level of Fibrin Degradation Products Cover

The Prothrombin Factor II G20210A Mutation with Pulmonary Thromboembolism and a Normal Level of Fibrin Degradation Products

Balkan Journal of Medical Genetics
Volume 12 (2009): Issue 2 (December 2009)
By: ,  ,  ,  ,  ,  ,   and    
Open Access
|Feb 2010
References

References

  1. Moser KM. Venous thromboembolism.1990; 141(1): 235-249.
    Open DOISearch in Google Scholar
  2. Balakrishnan J, Meziane MA, Siegelman SS, Fishman EK. Pulmonary infarction: CT appearance with pathologic correlation.1989; 13(6): 941-945.
    Open DOISearch in Google Scholar
  3. Parambil JG, Savci D, Tazelaar H, Ryu J. Causes and presenting features of pulmonary infarctions in 43 cases identified by surgical lung biopsy.2005; 127(4): 1178-1183.
    Open DOISearch in Google Scholar
  4. Wells PS. Integrated strategies for the diagnosis of venous thromboembolism.2007; 5(Suppl. 1): 41-50.
    Open DOISearch in Google Scholar
  5. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.1996; 88(10): 3698-3703.
    Open DOISearch in Google Scholar
  6. Wicki J, Perneger TV, Junod AF, Bouneameaux H, Perrier A. Assessing clinical probability of pulmonary embolism in the emergency ward: a simple score.2001; 161(1): 92-97.
    Open DOISearch in Google Scholar
  7. Greaves SM, Hart EM, Aberle DR. CT of pulmonary thromboembolism.1997; 18(5): 323-337.
    Open DOISearch in Google Scholar
  8. Goekoop RJ, Steeghs N, Niessen RW, Jonkers GJ, Dik H, Castel A, Werker-van Gelder L, Vlasveld LT, van Klink RC, Planken EV, Huisman MV. Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Well's simplified decision rule.2007; 97(1): 146-150.
    Open DOISearch in Google Scholar
  9. Kearon C, Ginsberg JS, Douketis J, Turpie AG, Bates SM, Lee AY, Crowther MA, Weitz JI, Brill-Edwards P, Wells P, Anderson DR, Kovacs MJ, Links LA, Julian JA, Bonilla LR, Gent M., Canadian Pulmonary Embolism Diagnosis Study(CANPEDS) Group. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial.2006; 144(11): 812-821.
    Open DOISearch in Google Scholar
  10. Perrier A, Desmarais S, Miron MJ, de Moerloose P, Lepage R, Slosman D, Didier D, Unqer PF, Patenaude JV, Bounameaux H. Non-invasive diagnosis of venous thrombomboembolism in outpatients.1999; 353 (9148): 190-195.
    Open DOISearch in Google Scholar
  11. Bounameaux H, de Moerloose P, Perrier A, Miron MJ. D-dimer testing in suspected venous thromboembolism: an update.1997; 90(7): 437-442.
    Open DOISearch in Google Scholar
  12. Oger E, Leroyer C, Bressollette L, Nonent M, Le Moigne E, Bizais Y, Amiral J, Grimaux M, Clavier J, Ill P, Abogral JF, Mottier D. Evaluation of a new, rapid, and quantitative D-dimer test in patients with suspected pulmonary embolism.1998; 158(1): 65-70.
    Open DOISearch in Google Scholar
  13. Lip GY, Lowe GD. Fibrin D-dimer: a useful clinical marker of thrombogenesis?1995; 89(3): 205-214.
    Open DOISearch in Google Scholar
  14. Karami-Djurabi R, Klok FA, Kooiman J, Velthuis SI, Nijkeuter M, Huisman MV. D-dimer testing in patients with suspected pulmonary embolism and impaired renal function.2009; 122(11); 1050-1053.
    Open DOISearch in Google Scholar
  15. Gibson NS, Sohne M, Gerdes VE, Nijkeuter M, Buller HR. The importance of clinical probability assessment in interpreting a normal D-dimer in patients with suspected pulmonary embolism.2008; 134(4): 789-793.
    Open DOISearch in Google Scholar
  16. Verhaeghe R, Moerloose P, Greer I, Huisman MV, Hustinx R, Monreal M, Mortelmans L, Perrier A, Remy-Jardin M, Torbicki A, van Beek EJR., and other participants of the working group "Management of Pulmonary Embolism." Diagnostic aspects of pulmonary embolism.2004; 9(27): 15-24.
    Open DOISearch in Google Scholar
  17. Ridker PM, Hennekens CH, Miletich JP. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.1999; 99(8): 999-1004.
    Open DOISearch in Google Scholar
  18. Salvati EA, Della Valle AG, Westrich GH, Rana AJ, Specht L, Weksler BB, Wang P, Glueck CJ. The John Charnley Award: heritable thrombophilia and development of the thromboembolic disease after total hip arthroplasty.2005; 441(8): 40-55.
    Open DOISearch in Google Scholar
  19. Yamamoto T, Ito M, Nagata S, Suzuki H, Tagawa A, Nagase M, Hishida AJ. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy.2000; 27(8): 2035-2037.
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10034-010-0007-7 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 69 - 75
Published on: Feb 19, 2010
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Surgical procedure,
Thromboembolism,
Cross-linked fibrin (D-dimer),
Factor II (FII) G20210A mutation,
Risk factor
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2010 Lj Nagorni-Obradovic, P Miljic, V Djordjevic, D Pešut, D Jovanovic, J Stojsic, R Stevic, D Radojkovic, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 12 (2009): Issue 2 (December 2009)
Previous article